CVRx (CVRX)
CVRx on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
2.1M
Short interest
settlement 2026-10-15
3.1
Days to cover
+0.7 days vs prior
43.1%
Short share of volume
2026-11-02
2,012
Fails to deliver
settlement 2026-10-09
Wed 4 Nov
Next earnings
estimated date
$73K
Insider flow, 90 days
1 buys, 1 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in CVRX is 2,137,363 shares, up 493,631 shares over the last month. Over the last 48 readings it ranged from 1,221,681 shares (15 April 2025) to 2,518,514 shares (31 October 2024). At the reported average volume of 691K shares a day that is 3.1 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/cvrx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 2,137,363 | +7.8% | 691,069 | 3.09 |
| 2026-09-30 | 1,982,426 | +20.6% | 826,036 | 2.40 |
| 2026-09-15 | 1,643,732 | -16.5% | 631,100 | 2.60 |
| 2026-08-31 | 1,968,589 | -16.5% | 815,056 | 2.42 |
| 2026-08-14 | 2,357,528 | +17.3% | 2,543,605 | 1.00 |
| 2026-07-31 | 2,009,524 | +4.3% | 253,282 | 7.93 |
| 2026-07-15 | 1,926,164 | +4.7% | 216,519 | 8.90 |
| 2026-06-30 | 1,838,965 | +4.7% | 343,340 | 5.36 |
| 2026-06-15 | 1,755,781 | -9.7% | 289,775 | 6.06 |
| 2026-05-29 | 1,944,377 | +2.0% | 260,457 | 7.47 |
| 2026-05-15 | 1,905,296 | +9.1% | 474,149 | 4.02 |
| 2026-04-30 | 1,746,275 | +4.7% | 268,058 | 6.51 |
| 2026-04-15 | 1,668,755 | -1.4% | 267,237 | 6.24 |
| 2026-03-31 | 1,692,878 | -5.3% | 217,856 | 7.77 |
| 2026-03-13 | 1,787,083 | -7.5% | 237,002 | 7.54 |
| 2026-02-27 | 1,932,071 | +28.1% | 589,427 | 3.28 |
| 2026-02-13 | 1,508,055 | -8.2% | 291,737 | 5.17 |
| 2026-01-30 | 1,642,563 | +23.4% | 482,241 | 3.41 |
| 2026-01-15 | 1,331,161 | -0.8% | 283,953 | 4.69 |
| 2025-12-31 | 1,341,627 | -10.2% | 197,301 | 6.80 |
| 2025-12-15 | 1,493,903 | +0.3% | 142,001 | 10.52 |
| 2025-11-28 | 1,489,582 | -0.4% | 257,709 | 5.78 |
| 2025-11-14 | 1,495,414 | -12.1% | 294,888 | 5.07 |
| 2025-10-31 | 1,701,092 | -5.3% | 186,122 | 9.14 |
| 2025-10-15 | 1,797,236 | -2.1% | 202,385 | 8.88 |
| 2025-09-30 | 1,836,209 | -2.0% | 202,087 | 9.09 |
| 2025-09-15 | 1,873,924 | -1.7% | 146,429 | 12.80 |
| 2025-08-29 | 1,906,998 | -1.6% | 212,593 | 8.97 |
| 2025-08-15 | 1,938,415 | -2.1% | 302,623 | 6.41 |
| 2025-07-31 | 1,979,127 | +10.6% | 385,785 | 5.13 |
| 2025-07-15 | 1,790,329 | +0.6% | 154,098 | 11.62 |
| 2025-06-30 | 1,779,547 | +8.1% | 172,866 | 10.29 |
| 2025-06-13 | 1,645,768 | +10.3% | 246,730 | 6.67 |
| 2025-05-30 | 1,491,380 | +0.9% | 314,162 | 4.75 |
| 2025-05-15 | 1,477,378 | +19.1% | 658,422 | 2.24 |
| 2025-04-30 | 1,240,371 | +1.5% | 334,369 | 3.71 |
| 2025-04-15 | 1,221,681 | -46.5% | 769,011 | 1.59 |
| 2025-03-31 | 2,283,733 | +0.8% | 151,625 | 15.06 |
| 2025-03-14 | 2,265,980 | +3.7% | 274,179 | 8.26 |
| 2025-02-28 | 2,185,846 | +13.5% | 206,180 | 10.60 |
| 2025-02-14 | 1,926,117 | +4.8% | 243,857 | 7.90 |
| 2025-01-31 | 1,838,109 | -9.9% | 274,223 | 6.70 |
| 2025-01-15 | 2,040,837 | +4.0% | 250,727 | 8.14 |
| 2024-12-31 | 1,961,441 | +0.6% | 148,771 | 13.18 |
| 2024-12-13 | 1,949,547 | -0.3% | 169,126 | 11.53 |
| 2024-11-29 | 1,954,942 | -5.1% | 210,248 | 9.30 |
| 2024-11-15 | 2,060,964 | -18.2% | 385,306 | 5.35 |
| 2024-10-31 | 2,518,514 | +4.8% | 536,895 | 4.69 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of CVRX volume is 43.1%, down 7.0 points over the last five sessions. Over the last 30 readings it ranged from 33.0% (28 October 2026) to 79.3% (15 October 2026). The latest reading is 7.0 points below the 30-session average of 50.1%, on 150K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 64K | 150K | 43.1% | 1,417 |
| 2026-10-30 | 72K | 160K | 44.9% | 785 |
| 2026-10-29 | 46K | 120K | 38.4% | 46 |
| 2026-10-28 | 142K | 431K | 33.0% | 200 |
| 2026-10-27 | 121K | 232K | 52.0% | 8,691 |
| 2026-10-26 | 54K | 108K | 50.1% | 0 |
| 2026-10-23 | 48K | 112K | 42.7% | 0 |
| 2026-10-22 | 65K | 153K | 42.6% | 20 |
| 2026-10-21 | 111K | 196K | 56.5% | 0 |
| 2026-10-20 | 60K | 172K | 34.9% | 0 |
| 2026-10-19 | 100K | 186K | 53.7% | 0 |
| 2026-10-16 | 109K | 193K | 56.6% | 0 |
| 2026-10-15 | 133K | 168K | 79.3% | 4 |
| 2026-10-14 | 452K | 645K | 70.1% | 6,200 |
| 2026-10-13 | 132K | 264K | 50.0% | 130 |
| 2026-10-12 | 126K | 254K | 49.6% | 0 |
| 2026-10-09 | 99K | 237K | 41.9% | 1,461 |
| 2026-10-08 | 77K | 176K | 43.6% | 0 |
| 2026-10-07 | 204K | 478K | 42.6% | 4,072 |
| 2026-10-06 | 164K | 289K | 57.0% | 0 |
| 2026-10-05 | 159K | 292K | 54.5% | 0 |
| 2026-10-02 | 303K | 649K | 46.7% | 28,322 |
| 2026-10-01 | 282K | 696K | 40.6% | 26,749 |
| 2026-09-30 | 884K | 2.0M | 44.9% | 103,199 |
| 2026-09-29 | 80K | 137K | 58.1% | 0 |
| 2026-09-28 | 103K | 151K | 68.0% | 0 |
| 2026-09-25 | 143K | 249K | 57.5% | 0 |
| 2026-09-24 | 159K | 360K | 44.1% | 2,100 |
| 2026-09-23 | 106K | 225K | 47.1% | 500 |
| 2026-09-22 | 190K | 327K | 58.2% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 9 October 2026, the fails-to-deliver balance in CVRX is 2,012 shares, up 1,932 shares over the last settlement date. Over the last 30 readings it ranged from 74 shares (4 September 2026) to 459,082 shares (10 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-09 | 2,012 | $1.68 | $3K |
| 2026-09-30 | 80 | $2.63 | $210 |
| 2026-09-14 | 513 | $2.88 | $1K |
| 2026-09-04 | 74 | $3.01 | $223 |
| 2026-09-02 | 3,885 | $3.04 | $12K |
| 2026-08-27 | 2,304 | $3.27 | $8K |
| 2026-08-21 | 18,392 | $2.84 | $52K |
| 2026-08-18 | 115 | $2.75 | $316 |
| 2026-08-17 | 49,894 | $3.08 | $154K |
| 2026-08-13 | 16,541 | $2.73 | $45K |
| 2026-08-10 | 459,082 | $2.39 | $1.1M |
| 2026-08-07 | 12,616 | $5.94 | $75K |
| 2026-08-06 | 3,282 | $5.58 | $18K |
| 2026-08-05 | 1,920 | $5.49 | $11K |
| 2026-08-03 | 979 | $5.18 | $5K |
| 2026-07-31 | 3,407 | $5.38 | $18K |
| 2026-07-29 | 14,483 | $4.95 | $72K |
| 2026-07-28 | 14,569 | $4.88 | $71K |
| 2026-07-27 | 14,554 | $4.74 | $69K |
| 2026-07-24 | 1,386 | $4.89 | $7K |
| 2026-07-23 | 459 | $5.09 | $2K |
| 2026-07-21 | 76 | $4.77 | $363 |
| 2026-07-17 | 22,891 | $5.39 | $123K |
| 2026-07-16 | 167 | $5.27 | $880 |
| 2026-07-15 | 4,418 | $5.16 | $23K |
| 2026-07-13 | 4,144 | $5.43 | $23K |
| 2026-07-10 | 3,845 | $5.20 | $20K |
| 2026-07-09 | 2,366 | $5.27 | $12K |
| 2026-07-07 | 224 | $5.63 | $1K |
| 2026-07-02 | 882 | $5.50 | $5K |
Insider trades
SEC Form 4, newest first. JSONOver the last 90 days CVRX insiders reported 1 open-market buy ($76K) against 1 sell ($3K), so the dollar flow leans toward buying. Latest filing: Binkowski Brent (CHIEF OPERATING OFFICER) on 2026-08-13.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-13 | Binkowski Brent | CHIEF OPERATING OFFICER | Buy | 26K | $2.91 | $76K | 57K |
| 2026-08-12 | Binkowski Brent | CHIEF OPERATING OFFICER | Sell | 1K | $2.55 | $3K | 30K |
| 2026-06-01 | SHADAN MARTHA | Director | Grant | 9K | $0.00 | $0 | 9K |
| 2026-06-01 | Hill, Mitch C. | Director | Grant | 9K | $0.00 | $0 | 9K |
| 2026-06-01 | Jain Mudit K. | Director | Grant | 9K | $0.00 | $0 | 14K |
| 2026-06-01 | Nielsen Kirk G. | Director | Grant | 9K | $0.00 | $0 | 9K |
| 2026-06-01 | SLATTERY JOSEPH P | Director | Grant | 9K | $0.00 | $0 | 39K |
| 2026-06-01 | DALE MICHAEL D | Director | Grant | 29K | $0.00 | $0 | 29K |
| 2026-06-01 | Ballinger Kevin J. | Director | Grant | 9K | $0.00 | $0 | 9K |
| 2026-03-02 | John Robert Allen | Chief Revenue Officer | Sell | 4K | $7.90 | $31K | 86K |
| 2026-03-02 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 1K | $7.90 | $10K | 61K |
| 2026-03-02 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | Sell | 2K | $7.90 | $14K | 97K |
| 2026-03-02 | Hykes Kevin | PRES & CEO | Sell | 8K | $7.90 | $61K | 284K |
| 2026-03-02 | Morrison Gregory | CHIEF HUMAN RESOURCES OFFICER | Grant | 34K | $0.00 | $0 | 34K |
| 2026-03-02 | Adamson Philip B. | Chief Medical Officer | Sell | 1K | $7.90 | $10K | 62K |
| 2026-02-27 | John Robert Allen | Chief Revenue Officer | Grant | 35K | $0.00 | $0 | 90K |
| 2026-02-27 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Grant | 45K | $0.00 | $0 | 62K |
| 2026-02-27 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | Grant | 61K | $0.00 | $0 | 98K |
| 2026-02-27 | Hykes Kevin | PRES & CEO | Grant | 159K | $0.00 | $0 | 292K |
| 2026-02-27 | Binkowski Brent | CHIEF OPERATING OFFICER | Grant | 15K | $0.00 | $0 | 32K |
| 2026-02-27 | Adamson Philip B. | Chief Medical Officer | Grant | 41K | $0.00 | $0 | 63K |
| 2026-02-20 | Jain Mudit K. | Director | Buy | 47K | $6.36 | $298K | 980K |
| 2026-02-18 | Jain Mudit K. | Director | Buy | 600 | $4.64 | $3K | 6K |
| 2025-11-26 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Sell | 6K | $10.03 | $64K | 4.0M |
| 2025-11-26 | JOHNSON & JOHNSON | TenPercentOwner | Sell | 6K | $10.03 | $64K | 4.0M |
| 2025-11-25 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Sell | 16K | $10.03 | $160K | 4.0M |
| 2025-11-24 | JOHNSON & JOHNSON | TenPercentOwner | Sell | 2K | $10.06 | $22K | 4.0M |
| 2025-11-21 | JOHNSON & JOHNSON | TenPercentOwner | Sell | 500 | $10.00 | $5K | 4.0M |
| 2025-11-12 | JOHNSON & JOHNSON | TenPercentOwner | Sell | 1K | $10.00 | $10K | 4.0M |
| 2025-11-07 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Sell | 200 | $10.00 | $2K | 4.1M |
| 2025-11-07 | JOHNSON & JOHNSON | 10% owner | Sell | 200 | $10.00 | $2K | 4.1M |
| 2025-11-06 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Sell | 52K | $10.21 | $534K | 4.1M |
| 2025-11-06 | JOHNSON & JOHNSON | 10% owner | Sell | 52K | $10.21 | $534K | 4.1M |
| 2025-08-11 | Binkowski Brent | CHIEF OPERATING OFFICER | Grant | 17K | $0.00 | $0 | 17K |
| 2025-05-15 | Nielsen Kirk G. | Director | Buy | 11K | $5.45 | $60K | 1.9M |
| 2025-05-14 | Nielsen Kirk G. | Director | Buy | 61K | $5.23 | $320K | 1.9M |
| 2025-05-13 | Jain Mudit K. | Director | Buy | 150 | $5.26 | $789 | 5K |
| 2025-05-13 | Nielsen Kirk G. | Director | Buy | 101K | $5.29 | $536K | 1.8M |
| 2025-05-12 | Hykes Kevin | PRES & CEO | Buy | 5K | $4.84 | $24K | 133K |
| 2025-05-12 | Jain Mudit K. | Director | Buy | 2K | $4.66 | $7K | 5K |
| 2025-05-12 | Nielsen Kirk G. | Director | Buy | 25K | $4.79 | $121K | 1.7M |
| 2025-02-28 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Grant | 16K | $0.00 | $0 | 17K |
| 2025-02-28 | Adamson Philip B. | Chief Medical Officer | Grant | 20K | $0.00 | $0 | 20K |
| 2025-02-28 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | Grant | 22K | $0.00 | $0 | 37K |
| 2025-02-28 | John Robert Allen | Chief Revenue Officer | Grant | 55K | $0.00 | $0 | 55K |
| 2025-02-28 | Hykes Kevin | PRES & CEO | Grant | 98K | $0.00 | $0 | 128K |
| 2024-11-21 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Gift | 1K | $0.00 | $0 | 835 |
| 2024-11-19 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Exercise or conversion | 3K | $5.14 | $13K | 3K |
| 2024-11-19 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 1K | $13.58 | $19K | 2K |
| 2024-08-15 | SLATTERY JOSEPH P | Director | Buy | 3K | $8.10 | $24K | 31K |
| 2024-08-08 | SLATTERY JOSEPH P | Director | Buy | 3K | $8.24 | $25K | 28K |
| 2024-08-06 | SLATTERY JOSEPH P | Director | Buy | 3K | $9.09 | $23K | 25K |
| 2024-08-05 | Hykes Kevin | PRES & CEO | Buy | 30K | $8.36 | $251K | 30K |
| 2024-03-25 | Palmer Craig E. | SVP, U.S. SALES | Exercise or conversion | 379 | $0.24 | $91 | 674 |
| 2024-03-25 | Palmer Craig E. | SVP, U.S. SALES | Exercise or conversion | 404 | $0.24 | $97 | 1K |
| 2024-03-25 | Palmer Craig E. | SVP, U.S. SALES | Exercise or conversion | 151 | $0.24 | $36 | 1K |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 79 | $5.14 | $406 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 158 | $0.24 | $38 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 189 | $0.24 | $45 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 165 | $0.24 | $40 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 118 | $0.24 | $28 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 71 | $0.24 | $17 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 23 | $0.24 | $6 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 85 | $0.24 | $20 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 758 | $0.24 | $182 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 489 | $0.24 | $117 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 584 | $0.24 | $140 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 300 | $0.24 | $72 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 442 | $1.19 | $526 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 252 | $3.96 | $998 | 4.1M |
| 2024-02-29 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise or conversion | 142 | $1.19 | $169 | 4.1M |
| 2024-02-23 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Gift | 2K | $0.00 | $0 | 805 |
| 2024-02-20 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Exercise or conversion | 5K | $5.14 | $26K | 5K |
| 2024-02-20 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 3K | $21.91 | $56K | 2K |
| 2024-02-16 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Exercise (in or at the money) | 608K | $0.16 | $97K | 4.1M |
| 2024-02-16 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Sell | 4K | $25.81 | $96K | 4.1M |
| 2024-01-29 | Yared Nadim | CHIEF EXECUTIVE OFFICER | Exercise or conversion | 4K | $0.24 | $973 | 24K |
| 2024-01-29 | Yared Nadim | CHIEF EXECUTIVE OFFICER | Exercise or conversion | 2K | $0.24 | $467 | 26K |
| 2023-12-28 | SLATTERY JOSEPH P | Director | Exercise or conversion | 174 | $1.19 | $207 | 22K |
| 2023-12-28 | SLATTERY JOSEPH P | Director | Exercise or conversion | 224 | $0.24 | $54 | 20K |
| 2023-12-28 | SLATTERY JOSEPH P | Director | Exercise or conversion | 96 | $3.96 | $380 | 22K |
| 2023-12-28 | SLATTERY JOSEPH P | Director | Exercise or conversion | 1K | $0.24 | $349 | 22K |
| 2023-12-14 | Behbahani Ali | Director | Exercise or conversion | 316 | $0.24 | $76 | 316 |
| 2023-10-16 | Galle Liz | VP OF GLOBAL CLINICAL RESEARCH | Exercise or conversion | 778 | $0.24 | $187 | 778 |
| 2023-09-18 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | Exercise or conversion | 527 | $0.24 | $126 | 10K |
| 2023-09-18 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | Exercise or conversion | 5K | $3.96 | $21K | 15K |
| 2023-09-15 | Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | Other transaction | 3.5M | price not stated in the filing | not stated | 0 |
| 2023-08-03 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 628 | $18.55 | $12K | 0 |
| 2023-08-02 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Gift | 2K | $0.00 | $0 | 628 |
| 2023-07-31 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Exercise or conversion | 4K | $5.14 | $19K | 4K |
| 2023-07-31 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 1K | $17.49 | $20K | 3K |
| 2023-05-16 | Palmer Craig E. | SVP, U.S. SALES | Exercise or conversion | 295 | $0.24 | $71 | 295 |
| 2023-01-11 | Yared Nadim | CHIEF EXECUTIVE OFFICER | Gift | 7K | $0.00 | $0 | 20K |
| 2022-11-30 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Gift | 4K | $0.00 | $0 | 0 |
| 2022-11-28 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 600 | $12.52 | $8K | 4K |
| 2022-11-28 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 4K | $11.85 | $47K | 5K |
| 2022-11-28 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Exercise or conversion | 9K | $5.14 | $46K | 9K |
| 2022-06-02 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | Exercise or conversion | 3K | $0.24 | $758 | 7K |
| 2022-06-02 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | Exercise or conversion | 3K | $0.24 | $607 | 4K |
| 2022-06-02 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | Exercise or conversion | 1K | $0.24 | $303 | 1K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON2 holders report 5% or more of CVRX in their latest filing, all on Schedule 13G (passive). The largest reported stake is JOHNSON & JOHNSON at 15.4% of the class (4,024,861 shares), filed 2026-01-12 for an event on 2025-12-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-02 | 13D/Ano. 1 | Chernett Joreyindividual | 165K | 0.6% | 2026-09-30 |
| 2026-01-12 | 13G/Ano. 3 | JOHNSON & JOHNSONcorporation | 4.0M | 15.4% | 2025-12-31 |
| 2026-01-12 | 13G/Ano. 3 | Johnson & Johnson Innovation - JJDC, Inc.corporation | 4.0M | 15.4% | 2025-12-31 |
13F holders
Tracked managers holding CVRX at their latest 13F. JSON6 of the 30 tracked managers held CVRX at their latest 13F, $3.0M in total at quarter-end prices. Renaissance Technologies is the largest at $1.2M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 6 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 230K | $1.2M | 0.00% | +211K |
| Two Sigma Investments | 2026-06-30 | 132K | $681K | 0.00% | +18K |
| AQR Capital Management | 2026-06-30 | 106K | $543K | 0.00% | +16K |
| Citadel Advisors | 2026-06-30 | 79K | $406K | 0.00% | +52K |
| Point72 Asset Management | 2026-06-30 | 27K | $138K | 0.00% | new |
| Millennium Management | 2026-06-30 | 16K | $84K | 0.00% | +3K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
CVRx in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows CVRx (CVRX), SEC CIK 1235912, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-02.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-13.JSON and CSV
- Company record
- EDGAR filing index for CIK 1235912Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of CVRX is sold short?
2,137,363 shares were held short at the 2026-10-15 settlement, 3.1 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is CVRX's daily short volume?
On 2026-11-02, 64,457 of the 149,561 CVRX shares reported to FINRA were sold short, 43.1% of the day's reported volume. Short volume is a flow for one day, not a position.
Does CVRX have fails to deliver?
The SEC's latest file shows 2,012 CVRX shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.
Are CVRX insiders buying or selling?
Over the last 90 days CVRX insiders reported 1 open-market buy ($76K) against 1 sell ($3K), so the dollar flow leans toward buying. Latest filing: Binkowski Brent (CHIEF OPERATING OFFICER) on 2026-08-13.
Who owns 5% or more of CVRX?
2 holders report 5% or more of CVRX in their latest filing, all on Schedule 13G (passive). The largest reported stake is JOHNSON & JOHNSON at 15.4% of the class (4,024,861 shares), filed 2026-01-12 for an event on 2025-12-31.
Which tracked 13F managers own CVRX?
6 of the 30 tracked 13F managers held CVRX shares at their latest filing, $3.0M in all. The largest: Renaissance Technologies (230K shares, $1.2M), Two Sigma Investments (132K shares, $681K), Cliff Asness's AQR Capital Management (106K shares, $543K), Ken Griffin's Citadel Advisors (79K shares, $406K), Steve Cohen's Point72 Asset Management (27K shares, $138K), Izzy Englander's Millennium Management (16K shares, $84K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.